PharmPRO
PharmPRO is a Private limited company (Ltd.) registered in Latvia under 50203187711, and its current status with API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework) is active. The company was incorporated on 28 December 2018 and lists its registered address as Latvia. 2 shareholders are on record for PharmPRO, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework) and was last updated on 28 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Two shareholders are currently on record for PharmPRO, filed with API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework).
The largest of these is AS "Paira", holding 75% — a majority holding — followed by Bāliņa Līga at 25%.
1 shareholder shown is a company, so the ownership chain continues above this level for that holding; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| AS "Paira" | 75% | API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework) | |
| Bāliņa Līga | 25% | API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework) |
Officers
1
One officer is currently on record for PharmPRO, filed with API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework). Baliņa Liga serves as Member Of The Board.
Management authority at PharmPRO sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
PharmPRO sits 1 level below its ultimate parent, Aktsiaselts PAIRA, registered in Estonia. The full chain up to Aktsiaselts PAIRA is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by PharmPRO's own shareholder record.
Aktsiaselts PAIRA
Estonia
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns PharmPRO?
Two shareholders are currently on record for PharmPRO, filed with API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework). The largest of these is AS "Paira", holding 75% — a majority holding — followed by Bāliņa Līga at 25%. 1 shareholder shown is a company, so the ownership chain continues above this level for that holding; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is PharmPRO's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for PharmPRO is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does PharmPRO have on record?
2 shareholders are shown on record for PharmPRO.
What is PharmPRO's company registration number?
PharmPRO's registration number is 50203187711, filed with API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework) in Latvia. Its current status on the register is active.
Is PharmPRO still an active company?
PharmPRO's status on API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework) is listed as active.
When was PharmPRO incorporated?
PharmPRO was incorporated on 28 December 2018, according to API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework).
What is PharmPRO's registered address?
The registered address on file for PharmPRO is Latvia.
What legal structure is PharmPRO registered as?
PharmPRO is registered as a Private limited company (Ltd.) in Latvia.
Who are the officers/directors of PharmPRO?
One officer is currently on record for PharmPRO, filed with API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework). Baliņa Liga serves as Member Of The Board. Management authority at PharmPRO sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does PharmPRO have a parent company or subsidiaries?
PharmPRO sits 1 level below its ultimate parent, Aktsiaselts PAIRA, registered in Estonia.
Can Zavia monitor changes to PharmPRO's ownership over time?
This profile reflects a point-in-time snapshot from API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework). Zavia's monitoring API can track changes to PharmPRO's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access PharmPRO's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Latvia, so records like PharmPRO's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from API-Mali — Agence pour la Promotion des Investissements au Mali (national guichet unique; OHADA framework) and was last synced on 28 October 2026.